US AI in Wound Care Market - Strategic Insights and Forecasts (2026-2031)

The US AI in Wound Care Market is projected to reach a market size of USD 3.9 billion by 2031, growing from USD 1.7 billion in 2026. This represents a robust Compound Annual Growth Rate (CAGR) of 18.8% over the forecast period, highlighting significant expansion and adoption.

The market's primary catalysts include the escalating prevalence of chronic wounds, particularly those linked to the increasing rates of diabetes and an aging US population. Additionally, regulatory clarity from the U.S. FDA on Software as a Medical Device (SaMD) and CMS coverage for active wound care management further incentivize demand for AI-powered solutions that enhance documentation accuracy for reimbursement claims.

Deep Learning (DL) technology, a critical subset of Machine Learning (ML), is the preferred technical approach dominating diagnostic accuracy in the US AI in Wound Care market. DL enables the development of highly accurate computer vision models for automated wound segmentation, tissue identification, and precise measurement, which are foundational for clinical utility.

The Hospitals end-user segment is a primary demand driver, concentrating on AI solutions that reduce the time-intensive and subjective nature of manual wound documentation. This focus directly translates into higher utilization of mobile imaging and analytics platforms, aiming for improved workflow efficiency and standardized wound assessment.

Regulatory clarity, specifically the U.S. FDA's development of a framework for Software as a Medical Device (SaMD) and its emphasis on Good Machine Learning Practices (GMLP), significantly accelerates adoption. This defined pathway mitigates risk for developers, providing a clear and expedited route for market entry for AI-powered diagnostics and solutions.

The US AI in Wound Care Market is undergoing a rapid transformation from traditional, subjective manual assessment methods to data-driven, objective digital management. This evolution is strategically important for post-acute care as AI-powered solutions become essential tools for standardizing assessments, enhancing early detection of complications, and supporting the growing trend of remote patient monitoring and telehealth integration.